Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Comparative analysis of T-cell costimulation and CD43 activation reveals novel signaling pathways and target genes.

Mattioli I, Dittrich-Breiholz O, Livingstone M, Kracht M, Schmitz ML.

Blood. 2004 Nov 15;104(10):3302-4. Epub 2004 Jul 27.

2.

CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes.

Santana MA, Pedraza-Alva G, Olivares-Zavaleta N, Madrid-Marina V, Horejsi V, Burakoff SJ, Rosenstein Y.

J Biol Chem. 2000 Oct 6;275(40):31460-8.

3.

Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells.

Brown TJ, Shuford WW, Wang WC, Nadler SG, Bailey TS, Marquardt H, Mittler RS.

J Biol Chem. 1996 Nov 1;271(44):27686-95.

4.

Regulation of Cbl molecular interactions by the co-receptor molecule CD43 in human T cells.

Pedraza-Alva G, Sawasdikosol S, Liu YC, Mérida LB, Cruz-Muñoz ME, Oceguera-Yañez F, Burakoff SJ, Rosenstein Y.

J Biol Chem. 2001 Jan 5;276(1):729-37.

5.

Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells.

Jung S, Yaron A, Alkalay I, Hatzubai A, Avraham A, Ben-Neriah Y.

Ann N Y Acad Sci. 1995 Sep 7;766:245-52.

PMID:
7486667
6.

Cyclosporin A inhibits the early phase of NF-kappaB/RelA activation induced by CD28 costimulatory signaling to reduce the IL-2 expression in human peripheral T cells.

Nishiyama S, Manabe N, Kubota Y, Ohnishi H, Kitanaka A, Tokuda M, Taminato T, Ishida T, Takahara J, Tanaka T.

Int Immunopharmacol. 2005 Apr;5(4):699-710.

PMID:
15710339
7.

Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells.

Hehner SP, Li-Weber M, Giaisi M, Dröge W, Krammer PH, Schmitz ML.

J Immunol. 2000 Apr 1;164(7):3829-36.

8.

PKCtheta is required for the activation of human T lymphocytes induced by CD43 engagement.

del Rio R, Rincón M, Layseca-Espinosa E, Fierro NA, Rosenstein Y, Pedraza-Alva G.

Biochem Biophys Res Commun. 2004 Dec 3;325(1):133-43.

PMID:
15522211
9.
11.
12.
13.

Complement regulatory protein Crry/p65-mediated signaling in T lymphocytes: role of its cytoplasmic domain and partitioning into lipid rafts.

Jiménez-Periañez A, Ojeda G, Criado G, Sánchez A, Pini E, Madrenas J, Rojo JM, Portolés P.

J Leukoc Biol. 2005 Dec;78(6):1386-96. Epub 2005 Nov 21.

PMID:
16301324
14.

The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.

Costello R, Cerdan C, Lipcey C, Algarté M, Martin Y, Baeuerle PA, Olive D, Imbert J.

Cell Growth Differ. 1993 Nov;4(11):947-54.

15.

Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals.

Edmead CE, Patel YI, Wilson A, Boulougouris G, Hall ND, Ward SG, Sansom DM.

J Immunol. 1996 Oct 15;157(8):3290-7.

PMID:
8871623
16.
17.
18.

TCR signaling induces selective exclusion of CD43 from the T cell-antigen-presenting cell contact site.

Sperling AI, Sedy JR, Manjunath N, Kupfer A, Ardman B, Burkhardt JK.

J Immunol. 1998 Dec 15;161(12):6459-62.

20.

Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody.

Silverman LB, Wong RC, Remold-O'Donnell E, Vercelli D, Sancho J, Terhorst C, Rosen F, Geha R, Chatila T.

J Immunol. 1989 Jun 15;142(12):4194-200.

PMID:
2542404

Supplemental Content

Support Center